RNS Number : 5063I

JPMorgan Securities Plc

12 August 2021

Ap24

AMENDMENT

FORM 38.5(a)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

Name of exempt principal trader	J.P. Morgan Securities Plc
Company dealt in	UDG Healthcare Plc
Class of relevant security to which the dealings being disclosed relate (Note 1)	€0.05 ordinary shares
Date of dealing	9 August 2021

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

370,561(New Borrow)*

571,520

N/A

10.7800 GBP

N/A

10.7550 GBP

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

112,823

10.7800 GBP

10.7000 GBP

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

Equity Swap

Decrease Long

Increase Long

Increase Short

Opening a long position

Opening a short position

1,774

19,717

474

2,443

354

502

860

25,559

7,468

23,981

1,179

16,782

13,700

2,745

333,333

10.7601 GBP

10.7699 GBP

10.7701 GBP

10.7705 GBP

10.7802 GBP

10.7298 GBP

10.7628 GBP

10.7684 GBP

10.7699 GBP

10.7700 GBP

10.7748 GBP

10.7794 GBP

10.7751 GBP

10.7622 GBP

10.7630 GBP

Ap25

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure	12 August 2021
Contact name	Alwyn Basch
Telephone number	020 7742 7407
Name of offeree/offeror with which connected	UDG Healthcare Plc
Nature of connection (Note 6)	Financial adviser to CD&R Fund XI

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEELLFFFVLLBBK ]]>